Chinese technology stocks have surged since DeepSeek R1's launch in late January, boosting investor confidence in China’s AI sector. The AI model, which competes with OpenAI’s ChatGPT using older hardware and a lower budget, has driven gains across internet and semiconductor stocks.
Since mid-January, the Shanghai Shenzhen CSI 300 index has risen 5%, while Hong Kong’s Hang Seng index has jumped nearly 15%. Despite concerns over trade and economic weakness, AI optimism has propelled markets forward.
UBS analysts highlighted that past tech rallies in China, such as the 4G, 5G, and cloud computing booms, lasted one to two years. Based on this, they believe the current AI-driven rally is far from over. However, they caution that earlier rallies were supported by stronger economic growth, whereas China in 2025 faces challenges like disinflation and weak consumer spending.
UBS noted that CSI 300 stocks have greater exposure to AI hardware and software, while Hong Kong’s market is concentrated in major software firms. The bank expects software stocks to see the most significant gains, as many remain well below their 2021 and 2023 peaks.
Top AI stock picks by UBS include JCET Group (SS:600584), Will Semiconductor (SS:603501), Baidu (NASDAQ:BIDU), Alibaba (NYSE:BABA), Tencent (HK:0700), JD Health (HK:6618), Li Auto (NASDAQ:LI), and CITIC Securities (SS:600030).
As AI developments accelerate, China’s tech sector remains a key focus for investors, driving continued momentum in the stock market.


PayPal Shares Sink as $50 Billion Takeover Bid Collapses
Countries Tighten Social Media Bans for Children
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns
Street Poller Media and The Boom of the Street Interview Ad Industry
Trian Drops Wendy’s Take-Private Bid Plans, Shares Plunge 14%
Nvidia Revenue Soars 106% as AI Demand Hits ‘Inflection Point’
SK Biopharmaceuticals Secures Global Rights to Biohaven Epilepsy Drug Opakalim
Google Changes EU Spam Policy Amid Antitrust Scrutiny
GM Plans C$1.1 Billion Canada Investment Amid U.S. Tariff Pressure
Meta, U.S. States Discuss Settlement in Teen Addiction Trial
Salesforce Shares Surge as AI Demand Powers Q2 Earnings Beat
U.S. Disrupts China-Linked Hacking Campaign Targeting Government Agencies
Jefferies Names AMEC Top China Semiconductor Equipment Pick
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 



